SLP (Simulations Plus) Receivables Turnover: 1.60 (As of Feb. 2026)


SLP Simulations Plus Inc SLP
81 GF Score
Price $18.38
GF Value $38.31
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Simulations Plus Receivables Turnover?

Simulations Plus SLP +0.22% 81 Receivables Turnover is 1.60 as of Feb. 2026. GuruFocus rates SLP with a GF Score™ of 81/100 and a GF Value™ of $38.31 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 655 Healthcare Providers & Services companies, Simulations Plus ranks worse than 66.26% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Simulations Plus's Revenue for the three months ended in Feb. 2026 was $24.29 Mil. Simulations Plus's average Accounts Receivable for the three months ended in Feb. 2026 was $15.16 Mil. Hence, Simulations Plus's Receivables Turnover for the three months ended in Feb. 2026 was 1.60.


Simulations Plus  (NAS:SLP) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Simulations Plus Receivables Turnover Related Terms


Simulations Plus Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Simulations Plus's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simulations Plus Receivables Turnover Chart

Simulations Plus Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.38 4.56 4.97 7.24 8.40

Simulations Plus Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.53 1.30 1.43 1.68 1.60

SLP vs TBRG, CARL, NRC: Receivables Turnover Comparison

For the Health Information Services subindustry, Simulations Plus's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus Receivables Turnover vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Receivables Turnover falls into.


SLP
81GF Score
Simulations Plus Inc SLP
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Simulations Plus Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Simulations Plus's Receivables Turnover for the fiscal year that ended in Aug. 2025 is calculated as

Receivables Turnover (A: Aug. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Aug. 2025 ) / ((Accounts Receivable (A: Aug. 2024 ) + Accounts Receivable (A: Aug. 2025 )) / count )
=79.179 / ((9.136 + 9.717) / 2 )
=79.179 / 9.4265
=8.40

Simulations Plus's Receivables Turnover for the quarter that ended in Feb. 2026 is calculated as

Receivables Turnover (Q: Feb. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Feb. 2026 ) / ((Accounts Receivable (Q: Nov. 2025 ) + Accounts Receivable (Q: Feb. 2026 )) / count )
=24.291 / ((12.154 + 18.17) / 2 )
=24.291 / 15.162
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 1.60 mean?
Simulations Plus (SLP) has a Receivables Turnover of 1.60 as of Feb. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Simulations Plus and its competitors. According to the industry distribution chart, Simulations Plus ranks #434 out of 655 companies in the Healthcare Providers & Services industry, placing it in the top 66.3%.
Is Simulations Plus' Receivables Turnover too high?
Simulations Plus' current Receivables Turnover is 1.60. The Healthcare Providers & Services industry median Receivables Turnover is 7.70. Simulations Plus' value of 1.60 is 79.2% below this industry median. Based on the distribution chart, Simulations Plus ranks #434 out of 655 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Simulations Plus has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Receivables Turnover compare to TBRG and CARL?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #434 out of 655 companies for Receivables Turnover. This places Simulations Plus in the lower half of its industry. The industry median Receivables Turnover is 7.70. Simulations Plus' value of 1.60 is 79.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.70, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simulations Plus's current Receivables Turnover of 1.60 is 79.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Simulations Plus and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simulations Plus's current Receivables Turnover is 1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (SLP) is currently considered Significantly Undervalued. The stock's GF Value™ is $38.31, compared to a current price of $18.38 — trading 52% below its estimated fair value. The current Receivables Turnover is 1.60 and 79.2% below the Healthcare Providers & Services industry median of 7.70. Simulations Plus' overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Simulations Plus (SLP), the current Receivables Turnover is 1.60 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Simulations Plus (SLP) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of $18.38 is trading 52% below its estimated GF Value™ of $38.31. GuruFocus considers Simulations Plus to be Significantly Undervalued.

Key valuation signals for SLP:

  • Receivables Turnover: 1.60
  • GF Value™: $38.31 vs. price of $18.38 (52% below fair value)
  • GF Score™: 81/100 with 7 warning signs
  • Industry Position: 79.2% below the Healthcare Providers & Services median (#434 of 655)

No single metric tells the full story. See the SLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Simulations Plus Business Description

Other Exchanges SD3:Germany
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
81GF Score

Get the complete analysis for SLP

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.38
Price
$38.31
GF Value